Deciphera Pharmaceuticals Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$270.4M
Industry:Pharma
Founded:2003
Lead Investor(s):Viking Global Investors LP, Redmile Group
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Deciphera Pharmaceuticals's estimated annual revenue is currently $12.9M per year.
  • Deciphera Pharmaceuticals received $128.0M in venture funding in October 2017.
  • Deciphera Pharmaceuticals's estimated revenue per employee is $41,902
  • Deciphera Pharmaceuticals's total funding is $270.4M.

Employee Data

  • Deciphera Pharmaceuticals has 307 Employees.
  • Deciphera Pharmaceuticals grew their employee count by 134% last year.
  • Deciphera Pharmaceuticals currently has 20 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ironwood Pharma...
N/A428N/AN/A
Infinity Pharma...
N/A395N/AN/A
Kala Pharmaceut...
$10.7M140-1%N/A
Karyopharm Ther...
$30.3M37050%N/A
Carna Bioscienc...
$4.6M23N/AN/A
Boston Pharmace...
$14.3M7148%N/A
Vita Data Scien...
$8.4M4250%N/A
Veristat
$38M22015%N/A
Radius Health
N/A436N/AN/A
Sunovion Pharma...
$465.5M2316N/AN/A
Missing a competitor? Contribute!?
Submit

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a 'switched off or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for patients with cancer by enhancing the quality, rate and/or durability of their responses to treatment.

keywords:Biotechnology,Healthcare,Pharmaceuticals

307

Number of Employees

$12.9M

Revenue (est)

20

Current Jobs

134%

Employee Growth %

$270.4M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Daniel Flynnevp/Founder & Chief Scientific Officer
Adam BranvoldSr. Director Global Field Medical Excellence
Mike KaufmanVice President Chemistry And Preclinical Development
Julie ToddAssociate Director Marketing Operations
Joe LiDirector of Biostatistics
Chelsea MencioSenior Manager, Medical Affairs
Irene CallenderAssociate Director, ITEmail Available
Simin HuAssociate DirectorEmail Available
Kristin TzetzoSr Human Resources Business Partner
Heather VitalSenior Director, Program Leadership

Deciphera Pharmaceuticals News

09/05/2019 - Deciphera Pharmaceuticals Announces Late-Breaking Oral ...

Deciphera Pharmaceuticals Announces Late-Breaking Oral Presentation of Pivotal Phase 3 INVICTUS Data at the European Society for ...

08/13/2019 - Here's Why Deciphera Pharmaceuticals Rose as Much as 115 ...

Shares of Deciphera Pharmaceuticals (NASDAQ:DCPH) erupted for gains of over 115% today after the clinical-stage pharma reported ...

08/14/2019 - Deciphera Pharmaceuticals Announces Pricing of Public ...

BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing ...

Deciphera Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2003-12-24$15.0MLead Investor: UndisArticle
2015-09-22$75.0MBNew Leaf Venture PartnersArticle
2016-01-06$90.0MBNew Leaf Venture PartnersArticle
2017-06-05$52.0MUndisclosedViking Global Investors LPArticle
2017-10-02$128.0MUndisclosedArticle

Deciphera Pharmaceuticals Executive Hires

DateNameTitleReference
2014-04-08Michael D. TaylorPresident/CEOArticle
2014-07-01Oliver RosenChief Medical OfficerArticle
2015-03-17Tucker KellyCFOArticle
2016-10-07Christopher J. MorlChief Business OfficerArticle
2018-05-30Stephen RuddyCTOArticle
2018-09-19Daniel MartinChief Commercial OfficerArticle

Deciphera Pharmaceuticals New Location/Offices

DateLocationReference
2014-04-08Boston, MAArticle